NFL Considers Adding Thanksgiving Eve Game to Schedule
The National Football League is exploring the possibility of adding a game on Thanksgiving Eve to its annual holiday schedule, building on the success of its Thanksgiving Day and Black Friday games. The move aims to capitalize on growing fan interest in NFL games during the Thanksgiving holiday period.
Thanksgiving Football Viewership Growth
Thanksgiving Day games are consistently among the most-watched regular-season NFL games. In 2023, the three Thanksgiving Day games averaged 44.7 million viewers, a significant increase from the 34.5 million viewers in 2022 ESPN. The late afternoon game between the Kansas City Chiefs and the Dallas Cowboys on CBS in 2023 averaged a record-breaking 57.2 million viewers, surpassing the previous record of 42.1 million set in 2022 between the Cowboys and the New York Giants ESPN.
The NFL has also experimented with a Black Friday game for the past three seasons, with viewership steadily increasing. In 2023, the game between the Chicago Bears and the Philadelphia Eagles on Amazon Prime Video averaged 16.3 million viewers ESPN.
League Statement and Potential Scheduling
The NFL released a statement on Wednesday, March 6, 2024, acknowledging the exploration of additional broadcast opportunities. “Every offseason we look for new opportunities to best serve our fans in the schedule-making process,” the league said. “As Commissioner (Roger) Goodell has said, Thanksgiving and NFL football have become synonymous and given the continued growth of fan interest around our games on Thanksgiving and Black Friday, looking for additional opportunities tied to this special holiday is exciting for us to explore.” ESPN.
If a Thanksgiving Eve game is added, teams participating would likely have a bye week prior to the game. This would provide them with extra rest and preparation time. A Thanksgiving Eve game would give the league nine major broadcast windows to fill, alongside existing games on Sunday and Monday nights.
Schedule Release and League Meetings
The NFL’s regular-season schedule is expected to be released in the first or second week of May. Team owners and network partners will have the opportunity to discuss and finalize plans during league meetings in Phoenix later this month ESPN.
- Understanding Graveyard-Recursion MTG Archetypes: Vengevine & Arclight Phoenix
- UCC Implementation in India: Political Rifts and Regional Opposition
- Breakthrough Salk Study Uncovers Mechanism Behind Immunotherapy Resistance: Interferons, Mitochondrial Dysfunction, and PGE2″ Interferons, mitochondrial dysfunction and PGE2: Salk study reveals mechanism behind immunotherapy resistance. Boost its search engine visibility with relevant keywords for maximum impact. Immunotherapy resistance remains one of the biggest hurdles in cancer treatment. According to a recent study published in the journal Nature Communications, scientists at the Salk Institute have made a groundbreaking discovery that sheds light on the underlying mechanisms behind this resistance. The study reveals that interferons, a type of protein that plays a crucial role in the immune system, can contribute to mitochondrial dysfunction in cancer cells. This dysfunction can lead to the production of prostaglandin E2 (PGE2), a molecule that promotes tumor growth and resistance to immunotherapy. In their study, the researchers found that PGE2 production was a key factor in the development of immunotherapy resistance in cancer cells. The team used a combination of experimental and computational models to investigate the relationship between interferons, mitochondrial dysfunction, and PGE2 production. The findings of the study suggest that targeting PGE2 production could be a potential strategy for overcoming immunotherapy resistance. The researchers propose that blocking PGE2 receptors or inhibiting its production could help restore the function of mitochondria in cancer cells, making them more susceptible to immunotherapy. The study’s authors hope that their findings will pave the way for the development of new therapies that can overcome immunotherapy resistance and improve treatment outcomes for cancer patients. Key Takeaways: – Interferons contribute to mitochondrial dysfunction in cancer cells – Mitochondrial dysfunction leads to PGE2 production, promoting tumor growth and resistance to immunotherapy – Targeting PGE2 production could be a potential strategy for overcoming immunotherapy resistance – Restoring mitochondrial function in cancer cells could make them more susceptible to immunotherapy Keywords: immunotherapy resistance, interferons, mitochondrial dysfunction, PGE2, Salk Institute, cancer treatment, breakthrough study, Nature Communications. (archyworldys.com)